{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T23:25:00Z","timestamp":1769037900406,"version":"3.49.0"},"reference-count":91,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T00:00:00Z","timestamp":1476921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T00:00:00Z","timestamp":1476921600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Autosomal dominant polycystic kidney disease (ADPKD) is the first genetic cause of end-stage renal disease (ESRD) and the number of these patients who are listed for or receive a kidney transplant (KTx) is continuously increasing over time. Hence, nephrologists are involved not only in the handling of ADPKD patients during the long course of the disease, but also in programming and performing a renal transplant. The handling of all these processes implies the complete awareness of a number of critical points related to the decisions to be taken both before and after the transplant intervention. In the present review, we will briefly deal with the main critical points related to the clinical handling of the patients both before and after KTx.<\/jats:p>","DOI":"10.1007\/s40620-016-0349-7","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T04:04:25Z","timestamp":1476936265000},"page":"755-763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["ADPKD: clinical issues before and after renal transplantation"],"prefix":"10.1093","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1512-559X","authenticated-orcid":false,"given":"Piergiorgio","family":"Messa","sequence":"first","affiliation":[{"name":"Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico di Milano, Universit\u00e0 agli studi di Milano, Area Omogenea Nefro-Urologica e Trapianto di Rene, Milan, Italy 1"},{"name":"Unit\u00e0 di Nefrologia e Dialisi, Universit\u00e0 agli studi di Milano, Milan, Italy 2"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo Maria","family":"Alfieri","sequence":"additional","affiliation":[{"name":"Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico di Milano, Universit\u00e0 agli studi di Milano, Area Omogenea Nefro-Urologica e Trapianto di Rene, Milan, Italy 1"},{"name":"Unit\u00e0 di Nefrologia e Dialisi, Universit\u00e0 agli studi di Milano, Milan, Italy 2"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Montanari","sequence":"additional","affiliation":[{"name":"Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico di Milano, Universit\u00e0 agli studi di Milano, Area Omogenea Nefro-Urologica e Trapianto di Rene, Milan, Italy 1"},{"name":"Unit\u00e0 di Urologia, Universit\u00e0 agli studi di Milano, Milan, Italy 3"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Ferraresso","sequence":"additional","affiliation":[{"name":"Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico di Milano, Universit\u00e0 agli studi di Milano, Area Omogenea Nefro-Urologica e Trapianto di Rene, Milan, Italy 1"},{"name":"Unit\u00e0 Chirurgia del Trapianto di Rene, Universit\u00e0 agli studi di Milano, Milan, Italy 4"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Cerutti","sequence":"additional","affiliation":[{"name":"Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico di Milano, Universit\u00e0 agli studi di Milano, Area Omogenea Nefro-Urologica e Trapianto di Rene, Milan, Italy 1"},{"name":"Unit\u00e0 di Nefrologia e Dialisi, Universit\u00e0 agli studi di Milano, Milan, Italy 2"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,10,20]]},"reference":[{"key":"2026012103464638300_CR1"},{"key":"2026012103464638300_CR2","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/S0140-6736(15)60907-2","article-title":"Autosomal dominant polycystic kidney disease: the changing face of clinical management","volume":"385","author":"Ong","year":"2015","journal-title":"Lancet"},{"issue":"Suppl 4","key":"2026012103464638300_CR3","doi-asserted-by":"publisher","first-page":"iv15","DOI":"10.1093\/ndt\/gfu017","article-title":"Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival\u2014an analysis of data from the ERA-EDTA Registry","volume":"29","author":"Spithoven","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"2026012103464638300_CR4","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1093\/ndt\/gfv327","article-title":"The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry","volume":"31","author":"Pippias","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"2026012103464638300_CR5","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1172\/JCI72272","article-title":"Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease","volume":"124","author":"Harris","year":"2014","journal-title":"J Clin Investig"},{"issue":"6","key":"2026012103464638300_CR6","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1681\/ASN.2015060648","article-title":"Refining genotype\u2013phenotype correlation in autosomal dominant polycystic kidney disease","volume":"27","author":"Hwang","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"2026012103464638300_CR7","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"2026012103464638300_CR8","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N Engl J Med"},{"issue":"25","key":"2026012103464638300_CR9","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"2026012103464638300_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2215\/CJN.06300615","article-title":"Effect of tolvaptan in autosomal dominant polycystic kidney disease by CKD stage: results from the TEMPO 3:4 Trial","volume":"11","author":"Torres","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9903","key":"2026012103464638300_CR11","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(13)61407-5","article-title":"Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial","volume":"382","author":"Caroli","year":"2013","journal-title":"Lancet"},{"key":"2026012103464638300_CR12","first-page":"CD010294","article-title":"Interventions for preventing the progression of autosomal dominant polycystic kidney disease","volume":"7","author":"Bolignano","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2026012103464638300_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/CEOR.S76269","article-title":"End-stage renal disease in autosomal dominant polycystic kidney disease: a comparison of dialysis-related utilization and costs with other chronic kidney diseases","volume":"7","author":"Brunelli","year":"2015","journal-title":"ClinicoEcon Outcomes Res"},{"issue":"1","key":"2026012103464638300_CR14","doi-asserted-by":"publisher","first-page":"c42","DOI":"10.1159\/000334429","article-title":"Survival after starting renal replacement treatment in patients with autosomal dominant polycystic kidney disease: a single-centre 40-year study","volume":"120","author":"Haynes","year":"2012","journal-title":"Nephron Clin Pract"},{"issue":"9","key":"2026012103464638300_CR15","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1097\/TP.0000000000000962","article-title":"Long-term kidney transplant outcomes in primary glomerulonephritis: analysis from the ERA-EDTA Registry","volume":"100","author":"Pippias","year":"2016","journal-title":"Transplantation"},{"issue":"8","key":"2026012103464638300_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneph.2014.104","article-title":"Renal transplantation in autosomal dominant polycystic kidney disease","volume":"10","author":"Kanaan","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"2026012103464638300_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"1","key":"2026012103464638300_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1053\/j.ajkd.2015.09.014","article-title":"GFR as the \u201cgold standard\u201d: estimated, measured, and true","volume":"67","author":"Levey","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2026012103464638300_CR19","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1681\/ASN.2005070697","article-title":"Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort","volume":"17","author":"Rule","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2026012103464638300_CR20","doi-asserted-by":"publisher","first-page":"e32533","DOI":"10.1371\/journal.pone.0032533","article-title":"Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort study","volume":"7","author":"Ruggenenti","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"2026012103464638300_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000341263","article-title":"Emergent early markers of renal progression in autosomal-dominant polycystic kidney disease patients: implications for prevention and treatment","volume":"36","author":"Helal","year":"2012","journal-title":"Am J Nephrol"},{"issue":"6","key":"2026012103464638300_CR22","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1681\/ASN.2012070650","article-title":"Type of PKD1 mutation influences renal outcome in ADPKD","volume":"24","author":"Cornec-Le Gall","year":"2013","journal-title":"J Am Soc \nNephrol"},{"issue":"11","key":"2026012103464638300_CR23","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1681\/ASN.2013111184","article-title":"Predictors of autosomal dominant polycystic kidney disease progression","volume":"25","author":"Schrier","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2026012103464638300_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int"},{"issue":"1","key":"2026012103464638300_CR25","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials","volume":"26","author":"Irazabal","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2026012103464638300_CR26","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1681\/ASN.2015010016","article-title":"The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease","volume":"27","author":"Cornec-Le Gall","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2026012103464638300_CR27"},{"issue":"3","key":"2026012103464638300_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/ndt\/gfv456","article-title":"Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on inherited kidney disorders and European renal best practice","volume":"31","author":"Gansevoort","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"2026012103464638300_CR29","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1053\/j.ajkd.2014.05.020","article-title":"ESRD from autosomal dominant polycystic kidney disease in the United States, 2001\u20132010","volume":"64","author":"Reule","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2026012103464638300_CR30","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":"Improved graft survival after renal transplantation in the United States, 1988\u20131996","volume":"342","author":"Hariharan","year":"2000","journal-title":"N Engl J Med"},{"key":"2026012103464638300_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/tri.12217","article-title":"Factors influencing long-term outcome after Kidney transplantation","volume":"27","author":"Legendre","year":"2014","journal-title":"Transpl Int"},{"issue":"8901","key":"2026012103464638300_CR32","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S0140-6736(94)92026-5","article-title":"Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1","volume":"343","author":"Ravine","year":"1994","journal-title":"Lancet"},{"issue":"1","key":"2026012103464638300_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD","volume":"20","author":"Pei","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"2026012103464638300_CR34","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/nep.12658","article-title":"KHA-CARI guideline recommendations for the diagnosis and management of autosomal dominant polycystic kidney disease","volume":"21","author":"Rangan","year":"2016","journal-title":"Nephrology"},{"issue":"Suppl 4","key":"2026012103464638300_CR35","doi-asserted-by":"publisher","first-page":"iv95","DOI":"10.1093\/ndt\/gfu186","article-title":"Spanish guidelines for the management of autosomal dominant polycystic kidney disease","volume":"29","author":"Ars","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"2026012103464638300_CR36","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1097\/TP.0000000000000466","article-title":"Genetic testing in the assessment of living related kidney donors at risk of autosomal dominant polycystic kidney disease","volume":"99","author":"Simms","year":"2015","journal-title":"Transplantation"},{"issue":"1","key":"2026012103464638300_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.gene.2012.12.060","article-title":"Genetic diagnosis of autosomal dominant polycystic kidney disease by targeted capture and next-generation sequencing: utility and limitations","volume":"516","author":"Qi","year":"2013","journal-title":"Gene"},{"issue":"2","key":"2026012103464638300_CR38","doi-asserted-by":"publisher","first-page":"e0116680","DOI":"10.1371\/journal.pone.0116680","article-title":"An efficient and comprehensive strategy for genetic diagnostics of polycystic kidney disease","volume":"10","author":"Eisenberger","year":"2015","journal-title":"PLoS One"},{"key":"2026012103464638300_CR39","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2215\/CJN.00080605","article-title":"Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort","volume":"1","author":"Bae","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026012103464638300_CR40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cgh.2014.07.051","article-title":"Liver involvement in early autosomal-dominant polycystic kidney disease","volume":"13","author":"Hogan","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"2026012103464638300_CR41","first-page":"27","article-title":"Recent advances on the mechanisms regulating cholangiocyte proliferation and the significance of the neuroendocrine regulation of cholangiocyte pathophysiology","volume":"1","author":"Franchitto","year":"2013","journal-title":"Ann Transl Med"},{"issue":"1","key":"2026012103464638300_CR42","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S0002-9378(98)70286-8","article-title":"Pregnancy complicated by symptomatic adult polycystic liver disease","volume":"179","author":"Kesby","year":"1998","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2026012103464638300_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1053\/jarr.2003.50005","article-title":"Cystic disease in women: clinical characteristics and medical management","volume":"10","author":"Chapman","year":"2003","journal-title":"Adv Ren Replace Ther"},{"issue":"4","key":"2026012103464638300_CR44","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ajmg.c.30225","article-title":"Liver and kidney disease in ciliopathies","volume":"151C","author":"Gunay-Aygun","year":"2009","journal-title":"Am J Med Genet C Semin Med \nGenet"},{"issue":"4","key":"2026012103464638300_CR45","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1445-2197.2006.03659.x","article-title":"Caroli\u2019s syndrome and adult polycystic kidney disease","volume":"77","author":"Shedda","year":"2007","journal-title":"ANZ J Surg"},{"issue":"7","key":"2026012103464638300_CR46","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/petr.12330","article-title":"Kidney and liver transplantation in children with fibrocystic liver-kidney disease: data from the US Scientific Registry of Transplant Recipients: 1990\u20132010","volume":"18","author":"Wen","year":"2014","journal-title":"Pediatr Transplant"},{"issue":"1","key":"2026012103464638300_CR47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/00000658-199007000-00005","article-title":"Treatment of highly symptomatic polycystic liver disease. Preliminary experience with a combined hepatic resection-fenestration procedure","volume":"212","author":"Newman","year":"1990","journal-title":"Ann Surg"},{"issue":"1","key":"2026012103464638300_CR48","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3748\/wjg.v5.i1.79","article-title":"A successful case of combined liver and kidney transplantation for autosomal dominant polycystic liver and kidney disease","volume":"5","author":"He","year":"1999","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2026012103464638300_CR49","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jamcollsurg.2015.12.051","article-title":"Outcomes and durability of hepatic reduction after combined partial hepatectomy and cyst fenestration for massive polycystic liver disease","volume":"223","author":"Chebib","year":"2016","journal-title":"J Am Coll Surg"},{"key":"2026012103464638300_CR50","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1056\/NEJMra052760","article-title":"Cerebral aneurysms","volume":"355","author":"Brisman","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"2026012103464638300_CR51","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1161\/STROKEAHA.110.578740","article-title":"Screening for intracranial aneurysm in 355 patients with autosomal-dominant polycystic kidney disease","volume":"42","author":"Xu","year":"2011","journal-title":"Stroke"},{"issue":"7","key":"2026012103464638300_CR52","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S1474-4422(11)70109-0","article-title":"Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis","volume":"10","author":"Vlak","year":"2011","journal-title":"Lancet Neurol"},{"issue":"1","key":"2026012103464638300_CR53","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1681\/ASN.V131269","article-title":"Management of cerebral aneurysms in autosomal dominant polycystic kidney disease","volume":"13","author":"Pirson","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2026012103464638300_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3174\/ajnr.A3437","article-title":"Should patients with autosomal dominant polycystic kidney disease be screened for cerebral aneurysms?","volume":"35","author":"Rozenfeld","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"2026012103464638300_CR55","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3174\/ajnr.A4490","article-title":"Autosomal dominant polycystic kidney disease and intracranial aneurysms: is there an increased risk of \ntreatment?","volume":"37","author":"Rozenfeld","year":"2016","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"2026012103464638300_CR56","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1227\/NEU.0000000000001068","article-title":"Endovascular treatment of intracranial aneurysms in patients with autosomal dominant polycystic kidney disease","volume":"78","author":"Jung","year":"2016","journal-title":"Neurosurgery"},{"issue":"2","key":"2026012103464638300_CR57","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000363378","article-title":"Nephrectomy in autosomal dominant polycystic kidney disease: a patient with exceptionally large, still functioning kidneys","volume":"4","author":"Spithoven","year":"2014","journal-title":"Case Rep Nephrol Urol"},{"issue":"7\u20138","key":"2026012103464638300_CR58","doi-asserted-by":"publisher","first-page":"278","DOI":"10.5489\/cuaj.2128","article-title":"Maximal kidney length predicts need for native nephrectomy in ADPKD patients undergoing renal transplantation","volume":"8","author":"Cristea","year":"2014","journal-title":"Can Urol Assoc J"},{"issue":"5","key":"2026012103464638300_CR59","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1308\/003588411X582690","article-title":"Native nephrectomy in transplant patients with autosomal dominant polycystic kidney disease","volume":"93","author":"Patel","year":"2011","journal-title":"Ann R Coll Surg Engl"},{"issue":"7","key":"2026012103464638300_CR60","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00345-016-1799-1","article-title":"Nephrectomy in patients with autosomal dominant polycystic kidney disease, does size matter?","volume":"34","author":"Casteleijn","year":"2016","journal-title":"World J Urol"},{"issue":"1","key":"2026012103464638300_CR61","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.juro.2015.07.114","article-title":"Native nephrectomy with renal transplantation is associated with a decrease in hypertension medication requirements for autosomal dominant polycystic kidney disease","volume":"195","author":"Shumate","year":"2016","journal-title":"J Urol"},{"issue":"2","key":"2026012103464638300_CR62","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.juro.2006.09.026","article-title":"Limitations of laparoscopy for bilateral nephrectomy for autosomal dominant polycystic kidney disease","volume":"177","author":"Lipke","year":"2007","journal-title":"J Urol"},{"issue":"1","key":"2026012103464638300_CR63","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/ndt\/gfv227","article-title":"Volume regression of native polycystic kidneys after renal transplantation","volume":"31","author":"Jung","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"2026012103464638300_CR64","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1097\/TP.0b013e318246f910","article-title":"Kidney volume changes in patients with autosomal dominant polycystic kidney disease after renal transplantation","volume":"93","author":"Yamamoto","year":"2012","journal-title":"Transplantation"},{"issue":"1","key":"2026012103464638300_CR65","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000324603","article-title":"Kidney transplant for autosomal dominant polycystic kidney disease: the superiority of concurrent bilateral nephrectomy","volume":"87","author":"Song","year":"2011","journal-title":"Urol Int"},{"issue":"4","key":"2026012103464638300_CR66","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/TP.0b013e31825812b9","article-title":"Kidney transplantation with and without simultaneous bilateral native nephrectomy in patients with polycystic kidney disease: a comparative retrospective study","volume":"94","author":"Skauby","year":"2012","journal-title":"Transplantation"},{"issue":"2","key":"2026012103464638300_CR67","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/ndt\/gfs118","article-title":"One hundred consecutive kidney transplantations with simultaneous ipsilateral nephrectomy in patients with autosomal dominant polycystic kidney disease","volume":"28","author":"Neeff","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2026012103464638300_CR68","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/TP.0000000000000838","article-title":"Live donor renal transplant with simultaneous bilateral nephrectomy for autosomal dominant polycystic kidney disease is feasible and satisfactory at long-term follow-up","volume":"100","author":"Ahmad","year":"2016","journal-title":"Transplantation"},{"issue":"6","key":"2026012103464638300_CR69","doi-asserted-by":"publisher","first-page":"e0129317","DOI":"10.1371\/journal.pone.0129317","article-title":"Laparoscopic nephrectomy versus open nephrectomy for patients with autosomal dominant polycystic kidney disease: a systematic review and meta-analysis","volume":"10","author":"Guo","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"2026012103464638300_CR70","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1007\/s00330-015-3730-3","article-title":"Embolization of renal arteries before transplantation in patients with polycystic kidney disease: a single institution long-term experience","volume":"25","author":"Petitpierre","year":"2015","journal-title":"Eur Radiol"},{"issue":"6","key":"2026012103464638300_CR71","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1432-2277.2011.01237.x","article-title":"Outcomes of renal transplantation in patients with autosomal dominant polycystic kidney disease: a nationwide longitudinal study","volume":"24","author":"Jacquet","year":"2011","journal-title":"Transpl Int"},{"key":"2026012103464638300_CR72","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/1471-2369-14-186","article-title":"Renal replacement therapy in ADPKD patients: a 25-year survey based on the Catalan Registry","volume":"14","author":"Mart\u00ednez","year":"2013","journal-title":"BMC Nephrol"},{"key":"2026012103464638300_CR73","doi-asserted-by":"crossref","first-page":"675697","DOI":"10.1155\/2014\/675697","article-title":"Trends in the management and outcomes of kidney transplantation for autosomal dominant polycystic kidney disease","volume":"2014","author":"Patel","year":"2014","journal-title":"J Transplant"},{"issue":"7","key":"2026012103464638300_CR74","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1111\/j.1600-6143.2010.03152.x","article-title":"Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: what is the appropriate serum level?","volume":"10","author":"Canaud","year":"2010","journal-title":"Am J Transplant"},{"issue":"5","key":"2026012103464638300_CR75","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2215\/CJN.05380709","article-title":"Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide","volume":"5","author":"Caroli","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"2026012103464638300_CR76","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1053\/j.gastro.2009.07.052","article-title":"Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial","volume":"137","author":"van Keimpema","year":"2009","journal-title":"Gastroenterology"},{"issue":"7","key":"2026012103464638300_CR77","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.2215\/CJN.01870309","article-title":"Cyst infections in patients with autosomal dominant polycystic kidney disease","volume":"4","author":"Sall\u00e9e","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2026012103464638300_CR78","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cmi.2015.09.024","article-title":"Diagnostic performance of [(18)F]fluorodeoxyglucose positron emission tomography-computed tomography in cyst infection in patients with autosomal dominant polycystic kidney disease","volume":"22","author":"Bobot","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2026012103464638300_CR79"},{"issue":"10","key":"2026012103464638300_CR80","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1681\/ASN.2013101122","article-title":"Polycystic kidney disease and cancer after renal transplantation","volume":"25","author":"Wetmore","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2026012103464638300_CR81","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1159\/000343281","article-title":"Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease","volume":"36","author":"Helal","year":"2012","journal-title":"Am J Nephrol"},{"issue":"4","key":"2026012103464638300_CR82","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1053\/ajkd.2001.27720","article-title":"Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality","volume":"38","author":"Perrone","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"2026012103464638300_CR83","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1432-2277.2004.tb00479.x","article-title":"Severe gastrointestinal complications after 1,515 adult kidney transplantations","volume":"17","author":"Sarkio","year":"2004","journal-title":"Transpl Int"},{"issue":"5","key":"2026012103464638300_CR84","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1053\/j.ajkd.2009.12.023","article-title":"Carbohydrate antigen 19-9 as a diagnostic marker \nfor hepatic cyst infection in autosomal dominant polycystic kidney disease","volume":"55","author":"Kanaan","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2026012103464638300_CR85","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/j.1600-6143.2004.00450.x","article-title":"Cancer after kidney transplantation in the United States","volume":"4","author":"Kasiske","year":"2004","journal-title":"Am J Transplant"},{"issue":"4","key":"2026012103464638300_CR86","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/ctr.12707","article-title":"Skin cancer in kidney transplant recipients affected with autosomal dominant polycystic kidney disease","volume":"30","author":"Jankowska","year":"2016","journal-title":"Clin Transplant"},{"key":"2026012103464638300_CR87","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/j.1523-1755.2002.kid582.x","article-title":"Patient survival after renal transplantation: IV. Impact of post-transplant diabetes","volume":"62","author":"Cosio","year":"2002","journal-title":"Kidney Int"},{"issue":"1","key":"2026012103464638300_CR88","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/01.tp.0000248759.37146.3d","article-title":"Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation","volume":"83","author":"Hamer","year":"2007","journal-title":"Transplantation"},{"issue":"1","key":"2026012103464638300_CR89","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1440-1797.2011.01507.x","article-title":"New onset diabetes after kidney transplantation in autosomal dominant polycystic kidney disease: a retrospective cohort study","volume":"17","author":"Ruderman","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"2026012103464638300_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2016.03.001","article-title":"The risk for new-onset diabetes mellitus after kidney transplantation in patients with autosomal dominant polycystic kidney disease: a systematic review and meta-analysis","author":"Cheungpasitporn","year":"2016","journal-title":"Can J Diabetes"},{"issue":"14","key":"2026012103464638300_CR91","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","article-title":"Clinical practice. Autosomal dominant polycystic kidney disease","volume":"359","author":"Grantham","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-016-0349-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-016-0349-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/29\/6\/755\/66030629\/joneph_29_6_349.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-016-0349-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/29\/6\/755\/66030629\/joneph_29_6_349.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T08:46:53Z","timestamp":1768985213000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/29\/6\/755\/8371311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,20]]},"references-count":91,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,10,20]]},"published-print":{"date-parts":[[2016,12,1]]}},"URL":"https:\/\/doi.org\/10.1007\/s40620-016-0349-7","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,12,1]]},"published":{"date-parts":[[2016,10,20]]}}}